The need to redefine antimicrobial drug discovery

Eleftherios Mylonakis

doi:10.2174/138161211795703762

The need to redefine antimicrobial drug discovery

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1223-1224
Number of pages	2
Journal	Current Pharmaceutical Design
Volume	17
Issue number	13
DOIs	https://doi.org/10.2174/138161211795703762
State	Published - May 2011

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Divisions

Infectious Disease

Access to Document

10.2174/138161211795703762

Cite this

@article{5c5789d6c5934280b44dc683b46e2788,

title = "The need to redefine antimicrobial drug discovery",

author = "Eleftherios Mylonakis",

year = "2011",

month = may,

doi = "10.2174/138161211795703762",

language = "English (US)",

volume = "17",

pages = "1223--1224",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers Ltd.",

number = "13",

}

TY - JOUR

T1 - The need to redefine antimicrobial drug discovery

AU - Mylonakis, Eleftherios

PY - 2011/5

Y1 - 2011/5

UR - https://www.scopus.com/pages/publications/79958178546

UR - https://www.scopus.com/inward/citedby.url?scp=79958178546&partnerID=8YFLogxK

U2 - 10.2174/138161211795703762

DO - 10.2174/138161211795703762

M3 - Article

C2 - 21470109

AN - SCOPUS:79958178546

SN - 1381-6128

VL - 17

SP - 1223

EP - 1224

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

IS - 13

ER -

The need to redefine antimicrobial drug discovery

ASJC Scopus subject areas

Divisions

Access to Document

Other files and links

Cite this